Also found in: Medical.
LAP2Lamina-Associated Polypeptide 2
LAP2Lamina-Associated Protein 2
LAP2Lipopolysaccharide-Associated Protein 2
LAP2Latency Active Promoter 2
LAP2Latency Associated Promoter 2
References in periodicals archive ?
The largest previous trial of more than 2,000 patients examining the method of surgical management was the Gynecologic Oncology Group's (GOG) noninferiority LAP2 trial.
The GOG trial, LAP2, supported the equivalent oncologic outcomes of MIS versus laparotomy for the treatment of endometrial cancer.